Sean McCutcheon
Stock Analyst at Raymond James
(0.18)
# 4,081
Out of 4,711 analysts
5
Total ratings
20%
Success rate
-21.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $5.83 | +294.51% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $24.13 | +65.77% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $48.87 | +43.24% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $34.08 | +152.35% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $5.83
Upside: +294.51%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $24.13
Upside: +65.77%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $48.87
Upside: +43.24%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $34.08
Upside: +152.35%